At first, the monovalent influenza A (H5N8) vaccine will be tested in two doses, 21 days apart, in adults aged 18–59.

Vaccine capacity would be far from adequate to protect a large share of the world’s population in the first year of a H5N1 bird ... It is based on an H5N8 virus and has the same key component as ...

The study in healthy adults 18 years of age and older is split into two stages, with part A evaluating four vaccine candidates against H5N8, H7N9, H5 only, and H7 only, and part B zeroing in on a ...

News of the cancellation came as Moderna revealed positive interim data from a phase 1/2 trial of its pandemic influenza vaccine, mRNA-1018, which targets the H5N8 bird flu subtype as well as ...

The authors note that the U.S. government is readying 4.8 million doses of stockpiled H5N8 vaccine, which is expected to offer cross-protection against current H5N1 strains.

In 2010, the H5N8 strain of HPAIV belonging to clade 2.3.4.4 was detected for the first time in wild Asian birds. The infection later spread among domestic birds in South Korea, Japan, and China.

At the same time, federal officials have prepared about 10 million doses of H5N8 vaccine that they think will be effective ...

At the same time, federal officials have prepared about 10 million doses of H5N8 vaccine that they think will be effective against H5N1 bird flu, in case the virus becomes more dangerous.